Akari interim CFO receives share awards

Farag Kameel D. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Farag Kameel D. reported acquisition or exercise transactions in this Form 4 filing.

Akari Therapeutics Plc interim CFO Farag Kameel D. received share awards in the form of American Depositary Shares (ADSs) representing ordinary shares. On June 24, 2026, multiple grant/award transactions (code A) increased his direct ADS holdings to 20,452 shares.

A footnote explains these ADS-related awards represent restricted stock units (RSUs), with each RSU giving the right to receive 80,000 ordinary shares. The RSUs vested in full on June 24, 2026, indicating these grants are compensation-related rather than open‑market purchases.

Insider Trade Summary

Grant/Award: 18,830 shares

Grant/Award 7 txns

Insider Farag Kameel D.

Role Interim CFO

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares representing Ordinary Shares	1,248	$10.02	$13K
Grant/Award	American Depositary Shares representing Ordinary Shares	1,395	$9.32	$13K
Grant/Award	American Depositary Shares representing Ordinary Shares	1,570	$8.28	$13K
Grant/Award	American Depositary Shares representing Ordinary Shares	2,539	$5.12	$13K
Grant/Award	American Depositary Shares representing Ordinary Shares	3,725	$3.49	$13K
Grant/Award	American Depositary Shares representing Ordinary Shares	7,353	$3.74	$28K
Grant/Award	American Depositary Shares representing Ordinary Shares	1,000	$13.00	$13K

Holdings After Transaction: American Depositary Shares representing Ordinary Shares — 20,452 shares (Direct)

Footnotes (1)

1. F1. These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026.

Key Figures

Post-transaction holdings: 20,452 ADS Grant example: 1,000 ADS at $13.00 Grant example: 7,353 ADS at $3.74 +3 more

6 metrics

Post-transaction holdings 20,452 ADS Direct holdings after June 24, 2026 grants

Grant example 1,000 ADS at $13.00 Grant/award acquisition on June 24, 2026

Grant example 7,353 ADS at $3.74 Grant/award acquisition on June 24, 2026

RSU ordinary share right 80,000 ordinary shares per RSU Footnote describing RSU structure

Transaction count 7 acquisitions All coded A as grant/award on June 24, 2026

Vesting date June 24, 2026 RSUs vested in full on this date

Key Terms

American Depositary Shares, restricted stock units ("RSUs"), grant/award acquisition, par value

4 terms

American Depositary Shares financial

"These American Depositary Shares represent restricted stock units ("RSUs")"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

restricted stock units ("RSUs") financial

"These American Depositary Shares represent restricted stock units ("RSUs")"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

par value financial

"ordinary shares with a par value of $0.000000005 per ordinary share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 08:06 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farag Kameel D.

(Last) (First) (Middle)

C/O AKARI THERAPEUTICS PLC

401 EAST JACKSON STREET, SUITE 3300

(Street)

TAMPA FLORIDA 33602

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Akari Therapeutics Plc [ AKTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares representing Ordinary Shares	06/24/2026		A		1,248(1)	A	$10.02	2,870	D
American Depositary Shares representing Ordinary Shares	06/24/2026		A		1,395(1)	A	$9.32	4,265	D
American Depositary Shares representing Ordinary Shares	06/24/2026		A		1,570(1)	A	$8.28	5,835	D
American Depositary Shares representing Ordinary Shares	06/24/2026		A		2,539(1)	A	$5.12	8,374	D
American Depositary Shares representing Ordinary Shares	06/24/2026		A		3,725(1)	A	$3.49	12,099	D
American Depositary Shares representing Ordinary Shares	06/24/2026		A		7,353(1)	A	$3.74	19,452	D
American Depositary Shares representing Ordinary Shares	06/24/2026		A		1,000(1)	A	$13	20,452	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026.

	/s/ Abizer Gaslightwala, as Attorney-in-Fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)